These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33753262)

  • 1. Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β
    Rancati F; Linney ID; Rizzi A; Delcanale M; Knight CK; Schmidt W; Pastore F; Riccardi B; Mileo V; Carnini C; Cesari N; Blackaby WP; Patacchini R; Carzaniga L
    Bioorg Med Chem Lett; 2021 Jun; 41():127975. PubMed ID: 33753262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivalent dual pharmacology muscarinic antagonist and β₂ agonist (MABA) molecules for the treatment of COPD.
    Hughes AD; McNamara A; Steinfeld T
    Prog Med Chem; 2012; 51():71-95. PubMed ID: 22520472
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of (a Combination of) the Beta
    Maarsingh H; Oldenburger A; Han B; Zuidhof AB; Elzinga CRS; Timens W; Meurs H; Sopi RB; Schmidt M
    Cells; 2021 May; 10(5):. PubMed ID: 34069899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β
    Carzaniga L; Linney ID; Rizzi A; Schmidt W; Knight CK; Mileo V; Amadei F; Pastore F; Miglietta D; Cesari N; Riccardi B; Mazzucato R; Ghidini E; Blackaby WP; Patacchini R; Battipaglia L; Villetti G; Puccini P; Catinella S; Civelli M; Rancati F
    J Med Chem; 2024 Jun; 67(12):9816-9841. PubMed ID: 38857426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M(2)-β(2) interaction: a basis for combined bronchodilator treatment.
    López-Campos JL
    Arch Bronconeumol; 2013 Jul; 49(7):279-81. PubMed ID: 23122560
    [No Abstract]   [Full Text] [Related]  

  • 6. Symptom variability and control in COPD: Advantages of dual bronchodilation therapy.
    Di Marco F; Santus P; Scichilone N; Solidoro P; Contoli M; Braido F; Corsico AG
    Respir Med; 2017 Apr; 125():49-56. PubMed ID: 28340862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Long-Acting Beta
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β
    Carzaniga L; Linney ID; Rizzi A; Delcanale M; Schmidt W; Knight CK; Pastore F; Miglietta D; Carnini C; Cesari N; Riccardi B; Mileo V; Venturi L; Moretti E; Blackaby WP; Patacchini R; Accetta A; Biagetti M; Bassani F; Tondelli M; Murgo A; Battipaglia L; Villetti G; Puccini P; Catinella S; Civelli M; Rancati F
    J Med Chem; 2022 Aug; 65(15):10233-10250. PubMed ID: 35901125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules.
    Hughes AD; Chin KH; Dunham SL; Jasper JR; King KE; Lee TW; Mammen M; Martin J; Steinfeld T
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1354-8. PubMed ID: 21310610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular hybridization yields triazole bronchodilators for the treatment of COPD.
    Jones LH; Burrows J; Feeder N; Glossop P; James K; Jones RM; Kenyon AS; Patel S; Roberts DF; Selby MD; Strang RS; Stuart EF; Trevethick MA; Watson J; Wright KN; Clarke N
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5121-6. PubMed ID: 26471092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends.
    Montuschi P; Ciabattoni G
    J Med Chem; 2015 May; 58(10):4131-64. PubMed ID: 25587755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled muscarinic acetylcholine receptor antagonists for treatment of COPD.
    Montuschi P; Macagno F; Valente S; Fuso L
    Curr Med Chem; 2013; 20(12):1464-76. PubMed ID: 22963553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological preclinical characterization of LAS190792, a novel inhaled bifunctional muscarinic receptor antagonist /β
    Aparici M; Carcasona C; Ramos I; Montero JL; Ortiz JL; Cortijo J; Puig C; Vilella D; Doe C; Gavaldà A; Miralpeix M
    Pulm Pharmacol Ther; 2017 Oct; 46():1-10. PubMed ID: 28729041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
    Petite SE
    Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Profile of AZD8871 (LAS191351), a Novel Inhaled Dual M
    Aparici M; Carcasona C; Ramos I; Montero JL; Otal R; Ortiz JL; Cortijo J; Puig C; Vilella D; De Alba J; Doe C; Gavaldà A; Miralpeix M
    J Pharmacol Exp Ther; 2019 Jul; 370(1):127-136. PubMed ID: 31085697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary disease.
    Hughes AD; Jones LH
    Future Med Chem; 2011 Oct; 3(13):1585-605. PubMed ID: 21942250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator.
    Singh D; Balaguer V; Astbury C; Wählby-Hamrén U; Jimenez E; Seoane B; Villarroel C; Lei A; Aggarwal A; Psallidas I
    Respir Res; 2020 Sep; 21(Suppl 1):102. PubMed ID: 32907566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.
    Mastrodicasa MA; Droege CA; Mulhall AM; Ernst NE; Panos RJ; Zafar MA
    Expert Opin Investig Drugs; 2017 Feb; 26(2):161-174. PubMed ID: 28004591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease.
    Tashkin DP; Gross NJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1873-1888. PubMed ID: 29928118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.